China's brain-computer interface (BCI) sector has witnessed a series of policy initiatives aimed at accelerating the development of the BCI industry chain. On Tuesday, the National Medical ...

Revelation Neuro, Inc. is focused on advancing development of a Non-Implantable Artificial Intelligence (“AI”) Powered BCI Technology-- --Helius’ existing IP portfolio and extensive data ...

AKRON, Ohio — The Ohio Bureau of Criminal Investigation (BCI) is investigating after a man has died following a shooting incident involving Akron police. According to officials, the shooting ...

In a report released today, Benjamin Jackson CFA from Jefferies maintained a Sell rating on Novo Nordisk (0QIU – Research Report), with a price target of DKK515.00. The company’s shares closed ...

Chinese researchers from the Tianjin University (TJU) and Tsinghua University have collaborated to develop the world's first "dual-loop" non-invasive brain-computer interface (BCI) system ...

Investing.com -- Novo Nordisk shares climbed more than 3% premarket on Tuesday after Hims&Hers Health announced it may no longer sell compounded versions of semaglutide, the active ingredient in ...

(Bloomberg) -- Novo Nordisk A/S shares plunged the most since December after another disappointment for the drugmaker’s next-generation shot CagriSema. The medicine helped patients with diabetes ...

No entanto, o que mais chamou a atenção foi a mudança do logo da empresa. A polêmica surgiu porque o símbolo é parecido com o escudo de uma pequena cidade da Ilha de Maiorca, na Espanha.

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030 ...

The FDA today declared the national deficit of GLP-1 diet drugs at an end. Well, at least for Novo Nordisk's Ozempic and Wegovy. Novo Nordisk sales should be going up, and Hims & Hers Health's ...